PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Antiviral Chemotherapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, 890-8544, Japan.\', \'Division of Antiviral Chemotherapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, 890-8544, Japan. Electronic address: m-baba@m2.kufm.kagoshima-u.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(20)30316-810.1016/j.antiviral.2020.104902
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 32739404
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all